Alvotech (ALVO) Liabilities and Shareholders Equity (2020 - 2025)
Alvotech filings provide 6 years of Liabilities and Shareholders Equity readings, the most recent being $1.5 billion for Q4 2025.
- On a quarterly basis, Liabilities and Shareholders Equity rose 21.75% to $1.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $5.5 billion, a 20.75% increase, with the full-year FY2025 number at $1.5 billion, up 21.75% from a year prior.
- Liabilities and Shareholders Equity hit $1.5 billion in Q4 2025 for Alvotech, up from $1.4 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.5 billion in Q4 2025 to a low of $598.0 million in Q4 2021.
- Median Liabilities and Shareholders Equity over the past 5 years was $1.1 billion (2024), compared with a mean of $1.1 billion.
- Biggest five-year swings in Liabilities and Shareholders Equity: soared 38.54% in 2022 and later grew 14.29% in 2025.
- Alvotech's Liabilities and Shareholders Equity stood at $598.0 million in 2021, then soared by 38.54% to $828.4 million in 2022, then grew by 14.68% to $950.1 million in 2023, then grew by 28.56% to $1.2 billion in 2024, then grew by 21.75% to $1.5 billion in 2025.
- The last three reported values for Liabilities and Shareholders Equity were $1.5 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.4 billion (Q2 2025) per Business Quant data.